Search

CytomX Therapeutics Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

3.83

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

3.65

Max

3.87

Pagrindiniai rodikliai

By Trading Economics

Pajamos

8.3M

-18M

Pardavimai

9.6M

10M

P/E

Sektoriaus vid.

22.5

60.549

Pelnas, tenkantis vienai akcijai

-0.1

Pelno marža

-177.89

Darbuotojai

69

EBITDA

9.5M

-18M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+208.07% upside

Dividendai

By Acuity

Kitas uždarbis

2026-08-06

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-81M

829M

Ankstesnė atidarymo kaina

3.83

Ankstesnė uždarymo kaina

3.83

Naujienos nuotaikos

By Acuity

50%

50%

160 / 342 reitingas Healthcare

CytomX Therapeutics Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-08 23:51; UTC

News

Broadcom shares rise in after-market hours as analysts project $172 billion in revenue next year, driven by AI infrastructure spending.

2026-07-08 23:51; UTC

News
Social Media

Costco Wholesale reported net sales of $29.24 billion for June but shares declined in after-hours trading amid mixed investor sentiment and broader market trends.

2026-07-08 23:46; UTC

News
ETF Constituents
Macro News
Correlated Moves

The Financial Select Sector SPDR Fund is higher in after-market trading, supported by strong seasonal patterns and movements in major bank holdings.

2026-07-08 23:41; UTC

News
Social Media
Correlated Moves

Advanced Micro Devices shares are declining in after-hours trading amid negative sentiment in semiconductor stocks, following the announcement of its upcoming earnings report.

2026-07-08 23:41; UTC

Social Media
News

NVIDIA Corp shares declined in after-market trading amid concerns over AI spending and competition. Analysts note cautious investor sentiment contributing to the bearish outlook.

2026-07-08 23:41; UTC

News
Social Media
Correlated Moves

Micron Technology shares traded higher after notable options activity, with $7.2 million in orders for $815 7/17 Puts contributing to a total premium of over $21.5 million.

2026-07-08 23:36; UTC

News

PayPal Holdings Inc. shares fell in after-market trading amid geopolitical tensions and investor risk aversion following President Trump's announcement on the Iran ceasefire.

2026-07-08 23:26; UTC

News

Lam Research Corporation will hold a financial conference call on July 29, 2026, to discuss June quarter results. Shares are higher in after-market trading.

2026-07-08 23:11; UTC

Correlated Moves
Macro News
ETF Constituents
News

The Consumer Discretionary Select Sector SPDR Fund is higher in after-market trading, bolstered by Levi Strauss & Co.'s strong Q2 results and summer performance trends.

2026-07-08 23:06; UTC

News

United Airlines shares traded lower in after-market hours following a judge's ruling to allow a class-action lawsuit over misleading "window seat" charges.

2026-07-08 23:06; UTC

News

Monster Beverage Corp announced a 2-for-1 stock split, effective August 10, 2026. Shares are trading higher in after-market hours following the news.

2026-07-08 23:06; UTC

Correlated Moves
News
Social Media
ETF Constituents

SPDR Dow Jones Industrial Average ETF Trust is lower in after-market hours, reflecting declines in key contributors amid rising inflation concerns from escalating Middle East tensions.

2026-07-08 23:01; UTC

News

Geopolitical tensions following U.S. strikes in Iran have boosted United States Oil Fund LP in after-market trading, reflecting strong upward momentum since Wednesday's close.

2026-07-08 20:13; UTC

ETF Constituents
Correlated Moves
News

The Vanguard Large-Cap ETF is lower in after-hours trading, reflecting broader market declines amid rising crude oil prices and escalating tensions in the Middle East.

2026-07-08 20:07; UTC

News
Correlated Moves

Bitcoin is trading lower amid heightened geopolitical tensions and rising inflation concerns. Earlier in the session, Bitcoin briefly declined significantly before recovering slightly.

2026-07-08 20:07; UTC

News
Correlated Moves

Geopolitical tensions following President Trump's U.S.-Iran ceasefire announcement support a modest rise in CAD/HKD during Wednesday's session. The pair is up since Tuesday's close.

2026-07-08 20:07; UTC

News
Correlated Moves

Bitcoin is trading lower amid heightened geopolitical tensions following President Trump's declaration on Iran. The asset remains under pressure from rising inflation concerns.

2026-07-08 20:06; UTC

Social Media
Macro Event
News

Cisco Systems Inc shares are higher today following the US Wholesale Inventories report, which showed a smaller-than-expected increase for May. Concerns about a price breakdown persist.

2026-07-08 20:04; UTC

News

J B Hunt Transport shares rise as Stephens initiates Overweight rating and TD Cowen raises price target to $265 ahead of earnings report.

2026-07-08 20:04; UTC

Correlated Moves
Social Media
News

Intuit Inc. shares are lower amid an investigation into potential securities fraud by Bleichmar Fonti & Auld LLP related to pricing issues ahead of tax season.

2026-07-08 20:04; UTC

Social Media
News
Correlated Moves

Amazon shares are lower as TD Cowen lowers its price target to $340 ahead of earnings, amid concerns over significant investments and high borrowing.

2026-07-08 20:04; UTC

News
Social Media
Correlated Moves

Alphabet Inc shares are lower despite confirmation of a major presence at the Calgary Stampede, reflecting broader market trends amid global tensions.

2026-07-08 20:04; UTC

News
Correlated Moves

Alphabet Inc shares are lower, affected by declines in the Interactive Media & Services sub-sector and a drop in the S&P 500 Index.

2026-07-08 20:04; UTC

Social Media
News
Correlated Moves

Meta Platforms Inc. shares are lower as France's competition authority mandates renewed negotiations with local media over unpaid publishing fees, amid broader market declines.

2026-07-08 20:04; UTC

Social Media
News
Correlated Moves

Qualcomm Inc is rising amid strong gains in the Semiconductors sector. Social media discussions note key resistance levels around $185.13 and $186.32.

2026-07-08 20:03; UTC

ETF Constituents
News
Correlated Moves

Vanguard Small-Cap ETF is lower as Goldman Sachs warns of waning favorable conditions for small-cap stocks amid rising interest burdens and declining holdings.

2026-07-08 20:03; UTC

Macro News
News
ETF Constituents
Correlated Moves

The Industrial Select Sector SPDR Fund is trading lower as rising oil prices and inflation concerns pressure the sector amid geopolitical tensions.

2026-07-08 20:02; UTC

News

Expedia Group Inc shares declined as geopolitical tensions rose after President Trump's Iran ceasefire remarks, raising concerns about travel demand and costs.

2026-07-08 20:02; UTC

News

NXP Semiconductors NV is trading higher, supported by Cantor Fitzgerald's endorsement and positive outlook for its automotive segment growth through 2027.

2026-07-08 19:57; UTC

Social Media
News

Tesla Inc. shares are lower today amid operational pressures and competitive developments, including scrutiny over Full Self-Driving and new competition in robotics.

Akcijų palyginimas

Kainos pokytis

CytomX Therapeutics Inc Prognozė

Kainos tikslas

By TipRanks

208.07% į viršų

12 mėnesių prognozė

Vidutinis 11.83 USD  208.07%

Aukščiausias 16 USD

Žemiausias 6 USD

Remiantis 6 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines CytomX Therapeutics Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

6 ratings

6

Pirkti

0

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

160 / 342 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę CytomX Therapeutics Inc

CytomX Therapeutics, Inc., an oncology-focused biopharmaceutical company, focuses on developing novel conditionally activated biologics localized to the tumor microenvironment. The company utilizes conditional activation platform technology for oncology biologics research and development comprising the validation of targets for antibody-drug conjugates (ADCs), opening therapeutic window for novel T-cell engagers (TCEs) targeting solid tumors, and increasing the therapeutic index for immune modulators, such as cytokines; and PROBODY platform in preclinical research in areas outside of oncology. It also develops CX-904, a T-cell-engaging bispecific antibody targeting the epidermal growth factor receptor (EGFR) on tumor cells and the CD3 receptor on T cells; CX-2051, a conditionally activated ADC for optimizing the therapeutic index for EpCAM-expressing epithelial cancers, including colorectal cancer; and CX-801, an interferon alpha-2b PROBODY cytokine. In addition, the company's development pipeline comprises CX-2029, a conditional activated ADC targeting CD71; and BMS-986288, a PROBODY version of non-fucosylated ipilimumab. It has strategic collaborations with Amgen, Astellas, Bristol Myers Squibb, Regeneron, and Moderna; and clinical trial collaboration and supply agreement with Merck for the evaluation of CX-801 in combination with anti-PD-1 therapy, KEYTRUDA (pembrolizumab). CytomX Therapeutics, Inc. was founded in 2008 and is headquartered in South San Francisco, California.
help-icon Live chat